Bayer’s Footprint in Costa Rica
Since launching operations in Costa Rica on July 1, 1978, Bayer has expanded its presence across multiple sectors. Today, the company operates through three core divisions—Pharmaceuticals, Consumer Health, and Crop Science—bringing health and agricultural innovation to the region. Bayer’s medical device manufacturing site in Heredia and its major production facility in Alajuela are central to its global supply chain, contributing to sustainable development goals by increasing access to contraceptive devices in low- and middle-income countries. In agriculture, Bayer leverages Costa Rica’s rich climate and fertile land for research and development at its sites in Cañas and Guácimo. Additionally, the country hosts Bayer’s Global Business Services for the Americas, underscoring Costa Rica’s role as a cornerstone of Bayer’s regional and global operations.
Why Costa Rica?
It’s no coincidence that Bayer chose Costa Rica as a strategic hub for its business investment. The decision is rooted in a single word: trust—a value built over more than 45 years of collaboration with Costa Ricans. Costa Rica offers a unique combination of assets that align perfectly with Bayer’s global vision: a highly qualified workforce capable of managing advanced technologies, a stable political and economic environment, and a strategic location that facilitates regional and global operations. The country’s commitment to sustainability and its forward-thinking policies that attract private investment have made it a natural partner for Bayer’s long-term growth in Latin America.
